24-Hour rhythms in oxidative stress during hepatocarcinogenesis in rats: effect of melatonin or α-ketoglutarate

REFERENCES

• IARC. N-nitrosodiethanolamine. IARC Monogr Eval Carcinog Risks Hum 2000; 77: 403–438.
   PubMedGoogle Scholar
• Loeppky RN. The mechanism of bioactivation of N-nitroso-diethanolamine. Drug Metab Rev 1999; 31: 175–193.
   PubMed Web of Science ®Google Scholar
• Dakshayani KB, Subramanian P, Manivasagam T, Mohamed EM. Metabolic normalization of alpha-ketoglutarate against N-nitrosodiethylamine-induced hepatocarcinogenesis in rats. Fundam Clin Pharmacol 2006; 20: 477–480.
   PubMed Web of Science ®Google Scholar
• Subramanian P, Mirunalini S, Dakshayani K, Pandi-Perumal SR, Trakht I, Cardinali DP. Prevention by melatonin of hepato-carcinogenesis in rats injected with N-nitrosodiethylamine. J Pineal Res 2007; 43: 305–312.
   PubMed Web of Science ®Google Scholar
• Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol 2007; 47: 593–628.
   PubMed Web of Science ®Google Scholar
• Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003; 3: 350–361.
   PubMed Web of Science ®Google Scholar
• Dakshayani KB, Subramanian P. Alpha-ketoglutarate modulates the circadian patterns of lipid peroxidation and antioxidant status during N-nitrosodiethylamine-induced hepatocarcinogenesis in rats. J Med Food 2006; 9: 90–97.
   PubMed Web of Science ®Google Scholar
• Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev2005; 9: 25–39.
   PubMed Web of Science ®Google Scholar
• Cardinali DP, Furio AM, Reyes MP, Brusco LI. The use of chronobiotics in the resynchronization of the sleep-wake cycle. Cancer Causes Control 2006; 17: 601–609.
   PubMed Web of Science ®Google Scholar
• Muzio G, Marengo B, Salvo R, Semeraro A, Canuto RA, Tessitore L. Liver cancer is induced by a subnecrogenic dose of DENA when associated with fasting/refeeding: role of glutathione-transferase and lipid peroxidation. Free Radic Biol Med 1999; 26: 1314–1320.
   PubMed Web of Science ®Google Scholar
• Sundaresan S, Subramanian P. S-Allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in N-nitrosodiethylamine-induced carcinogenesis. Pol J Pharmacol 2003; 55: 37–42.
   PubMedGoogle Scholar
• Dakshayani KB, Subramanian P, Manivasagam T, Essa MM, Manoharan S. Melatonin modulates the oxidant-antioxidant imbalance during N-nitrosodiethylamine induced hepatocarcinogenesis in rats. J Pharm Pharm Sci 2005; 8: 316–321.
   PubMed Web of Science ®Google Scholar
• Velvizhi S, Dakshayani KB, Subramanian P. Protective influences of alpha-ketoglutarate on lipid peroxidation and antioxidant status in ammonium acetate treated rats. Indian J Exp Biol 2002; 40: 1183–1186.
   PubMedGoogle Scholar
• Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957; 28: 56–63.
   PubMed Web of Science ®Google Scholar
• Niehaus Jr WG, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968; 6: 126–130.
   PubMedGoogle Scholar
• Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70–79.
   PubMed Web of Science ®Google Scholar
• Kakkar P, Das B, Viswanathan A. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 1984; 21: 130–132.
   PubMed Web of Science ®Google Scholar
• Sinha KA. Colorimetric assay of catalase. Anal Biochem 1972; 47: 3889–3894.
   Web of Science ®Google Scholar
• Rotruck JT, Pope AL, Gauther HE, Swanson AB, Hafeman DG, Hoekstna WG. Selenium: biochemical roles as component of glutathione peroxidase. Science 1973; 179: 588–590.
   PubMed Web of Science ®Google Scholar
• Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130–7139.
   PubMed Web of Science ®Google Scholar
• Nelson W, Tong YL, Lee JK, Halberg F. Methods for cosinor-rhythmometry. Chronobiologia 1979; 6: 305–323.
   PubMedGoogle Scholar
• Archer MC. Mechanisms of action of N-nitroso compounds. Cancer Surv 1989; 8: 241–250.
   PubMedGoogle Scholar
• Ozben T. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 2007; 96: 2181–2196.
   PubMed Web of Science ®Google Scholar
• Flora SJ. Role of free radicals and antioxidants in health and disease. Cell Mol Biol (Noisy-le-grand) 2007; 53: 1–2.
   PubMed Web of Science ®Google Scholar
• Hirst DG, Robson T. Nitrosative stress in cancer therapy. Front Biosci 2007; 12: 3406–3418.
   PubMed Web of Science ®Google Scholar
• Serafini M, Villano D, Spera G, Pellegrini N. Redox molecules and cancer prevention: the importance of understanding the role of the antioxidant network. Nutr Cancer 2006; 56: 232–240.
   PubMed Web of Science ®Google Scholar
• Otteneder MB, Knutson CG, Daniels JS et al. In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dG. Proc Natl Acad Sci USA 2006; 103: 6665–6669.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Tenon MP, Flores LJ, Czarnocki Z. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007; 54: 1–9.
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28–42.
   PubMed Web of Science ®Google Scholar
• Osseni RA, Rat P, Bogdan A, Warnet JM, Touitou Y. Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 2000; 68: 387–399.
   PubMed Web of Science ®Google Scholar
• Wolfler A, Caluba HC, Abuja PM, Dohr G, Schauenstein K, Liebmann PM. Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells. FEBS Lett 2001; 502: 127–131.
   PubMed Web of Science ®Google Scholar
• Sakano K, Oikawa S, Hiraku Y, Kawanishi S. Oxidative DNA damage induced by a melatonin metabolite, 6-hydroxymelatonin, via a unique non-o-quinone type of redox cycle. Biochem Pharmacol 2004; 68: 1869–1878.
   PubMed Web of Science ®Google Scholar
• Imaida K, Hagiwara A, Yoshino H et al. Inhibitory effects of low doses of melatonin on induction of preneoplastic liver lesions in a medium-term liver bioassay in F344 rats: relation to the influence of electromagnetic near field exposure. Cancer Lett 2000; 155: 105–114.
   PubMed Web of Science ®Google Scholar
• van den HS, Depres-Brummer P, Barbason H, Claustrat B, Reynes M, Levi F. The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci 1999; 64: 2523–2534.
   PubMed Web of Science ®Google Scholar
• Levi F. Circadian chronotherapy for human cancers. Lancet Oncol 2001; 2: 307–315.
   PubMed Web of Science ®Google Scholar
• Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000; 92: 994–1000.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A, Krauchi K, Cajochen C, Danilenko KV, Renz C, Weber JM. Evening melatonin and bright light administration induce additive phase shifts in dim light melatonin onset. J Pineal Res 2004; 36: 192–194.
   PubMed Web of Science ®Google Scholar
• Moser M, Schaumberger K, Schernhammer E, Stevens RG. Cancer and rhythm. Cancer Causes Control 2006; 17: 483–487.
   PubMed Web of Science ®Google Scholar
• Filipski E, Li XM, Levi F. Disruption of circadian coordination and malignant growth. Cancer Causes Control 2006; 17: 509–514.
   PubMed Web of Science ®Google Scholar
• Lee CC. Tumor suppression by the mammalian Period genes. Cancer Causes Control 2006; 17: 525–530.
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 2006; 1757: 573–589.
   PubMed Web of Science ®Google Scholar
• Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 2005; 27: 179–188.
   PubMed Web of Science ®Google Scholar
• Subramanian P, Mirunalini S, Pandi-Perumal SR, Trakht I, Cardinali DP. Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats. Eur J Pharmacol 2007; 571: 116–119.
   PubMed Web of Science ®Google Scholar